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What are the benefits of phenotypic heterogeneity?
The ability of bacterial populations to develop phenotypically heterogeneous subpopulations has
been recognized for decades. A recent study found that genetic hallmarks of phenotypic heteroge-
neity are ubiquitous among bacterial species of the intestinal microbiota [1], underscoring that
this is a broadly employed, underappreciated survival strategy for both pathogenic and commen-
sal bacterial species. Phenotypic heterogeneity—functional diversity among genetically identical
cells—can permit division of labor and cooperative behaviors or serve as a bet-hedging strategy to
help ensure the survival of the population as a whole. Division of labor occurs when biological
processes are separated among subpopulations, conferring an overall fitness advantage to the pop-
ulation. For example, the opportunistic pathogen Pseudomonas aeruginosa forms multiple unique
cell types that perform specialized roles in the formation of biofilm. Some cells contribute to bio-
film extracellular matrix production and initiate biofilm development, while others exhibit surface
motility and allow biofilm expansion [2]. In the bet-hedging strategy, incorporating phenotypic
variants into a population increases the likelihood that some members will survive a stress. In set-
tings where environmental changes are rapid and stark, phenotypic heterogeneity helps ensure
the survival of the population at the expense of individuals not well suited to the current environ-
ment, which are selected against and lost. This strategy is advantageous over traditional sense-
and-respond mechanisms, which require an adaptation time that may be insufficient in the face
of sudden or severe environmental changes. Mechanisms of phenotypic heterogeneity may be
particularly important in the context of disease, as these mechanisms are more common in host-
associated bacteria than in aquatic or terrestrial species [1].
How does phase variation result in phenotypic heterogeneity?
Phase variation is among the best characterized processes of generating phenotypic heteroge-
neity. Phase variation typically involves an ON and OFF switch in a phenotype that contributes
to fitness in one environment but that may have a fitness cost in a different condition [3]. A
number of genetic mechanisms that result in phase variation of a gene have been described,
including slipped-strand mispairing in repetitive nucleotide tracts, DNA inversions by site-
specific recombinases, and allele shuffling by recombination (reviewed in [4]). These mecha-
nisms have in common stochasticity, heritability, and reversibility, allowing the bacterial pop-
ulation to exhibit and regenerate phenotypic heterogeneity.
The insertion or deletion of nucleotides by slipped-strand mispairing during replication of
repetitive DNA tracts, known as short sequence repeats (SSR), is one means of altering gene
expression. Variations in the number of nucleotides within an SSR in a coding sequence may
cause a frameshift mutation that creates a premature stop codon and a truncated product
(OFF) or, conversely, may restore the reading frame and production of the gene product
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(ON). Changes in an SSR within a promoter can alter transcription factor binding sites, lead-
ing to changes in the transcription initiation of a gene.
Phase variation by site-specific DNA recombination is mediated by a site-specific recombi-
nase that binds to inverted repeats and catalyzes inversion of the sequence between the repeats.
The invertible sequence itself contains regulatory information that, when properly oriented,
impacts the expression of an adjacent gene or operon (Fig 1, top). The best characterized mecha-
nisms involve an invertible element containing a transcriptional promoter that initiates expres-
sion when oriented toward a coding sequence (ON) but not when inverted (OFF) [5, 6].
Alternatively, the orientation of the invertible element may regulate a factor by a post-transcrip-
tional mechanism, as has been suggested for phase variation of the cell wall protein CwpV and
flagella in Clostridioides difficile [7, 8]. Finally, phase variation can be achieved by shuffling alleles
of the same gene between an expressed locus and a distal, silent locus. This mechanism results in
a heterogeneous yet clonal bacterial population expressing different allelic variants of a factor.
Regardless of mechanism, the phenotypic makeup of the population is driven by environ-
mental selection, often leading to a strong bias in the population for a specific variant. After
cessation of a selective pressure, phenotypic heterogeneity can be restored, typically within sev-
eral generations. Though phase variation events are stochastic, regulation of factors that influ-
ence the rate of switching impacts phase variation and the population makeup [9].
What are common regulatory targets of phase variation?
Phase variation typically regulates the production of complex structures, such as flagella, pili,
fimbriae, and exopolysaccharides [3]. These structures are exposed on the bacterial surface
and directly interface with the cell’s environment. In the case of bacterial pathogens, these fac-
tors are thought to promote infection by contributing to colonization (e.g., pili) or evading
immune clearance (e.g., capsule). However, production of these factors comes at a cost, includ-
ing the energy cost of biosynthesizing complex macromolecules and/or the cost of host innate
immune recognition (e.g., flagella). Given the cost and benefit trade-offs, the dynamics of
phase variation are attuned to the environmental niches and pressures experienced by individ-
ual bacteria through the course of an infection.
Phase-locked mutants that cannot phase vary, e.g. due to mutation of a recombinase gene
or inverted repeats, are valuable tools for defining the role of phase variation of a factor. In E.
coli, phase variation of type 1 fimbriae occurs through site-specific recombination of a pro-
moter-containing invertible element upstream of the fimbrial subunit gene, fimA [10]. These
fimbriae promote colonization of the bladder epithelium in uropathogenic E. coli [11]. Consis-
tent with this result, phase-locked OFF mutants lacking fimbriae are attenuated in disease
models of urinary tract infection [12, 13]. A more complicated regulatory scheme involving an
invertible promoter regulates the transcription of alternate flagellin genes in Salmonella enter-
ica. In both E. coli and S. enterica, while the surface structure positively impacts aspects of
pathogenesis, the specific role of phase variation is unclear—why employ phase variation
rather than typical regulatory mechanisms? Presumably, as described above, heterogeneity
provides protection against rapid environmental changes and immune recognition. Investigat-
ing the spatial and temporal dynamics of phase variation of these structures during the course
of infection could reveal additional information about the roles of these factors as well as allow
inferences about the host selective pressures impacting the population.
How does phase variation mediate global changes in gene expression?
In addition to ON and OFF switching of the production of surface factors, phase variation can
broadly affect bacterial physiology. Some DNA methyltransferases, enzymes that methylate
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Fig 1. Phase variation can result in singular versus global regulation of cellular factors. Phase variation via site-specific DNA
recombination involves the inversion of a regulatory sequence by a serine or tyrosine recombinase. The recombinase binds
flanking inverted repeats (LIRs and RIRs) and catalyzes the inversion of the intervening sequence. The orientation of the
invertible element determines whether the downstream gene(s) are expressed (ON) or not (OFF). Top: In a simple system,
recombination inverts a single element, controlling the expression of a single factor. Fimbrial phase variation in Escherichia coli
is controlled in this manner. Middle: In a more complex scenario, a single recombinase inverts multiple elements. Inversion of
the elements occurs stochastically and independently, yielding multiple discrete genetic combinations and phenotypic variants,
thus allowing one recombinase to influence bacterial phenotypes on a broader scale. As an example, in C. difficile, the
recombinase RecV inverts sequences upstream of multiple genes including those encoding CwpV, flagella, and intracellular
factors [19, 22, 31]. Bottom: Phase variation of a single regulator, such as a transcription factor, results in a coordinated switch in
multiple phenotypes regulated by that factor. LIR, left inverted repeat; RIR, right inverted repeat.
https://doi.org/10.1371/journal.ppat.1008439.g001
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specific nucleotide motifs, are subject to phase variation, resulting in a population of bacteria
with different methylation patterns. Because methylation can influence gene expression,
methyltransferase phase variation can influence the transcription of multiple genes simulta-
neously. Such phase variable regulons, often referred to as phasevarions, include genes
involved in colonization and pathogenesis in several pathogens [14, 15]. Streptococcus pneumo-
niae contains six alleles encoding the type I methyltransferase SpnD39III HsdS
(SPND39IIIA-F). Recombination-mediated shuffling between the hsdS alleles results in
expression of different allelic variants and heterogeneity in genomic methylation patterns
within the population, impacting the expression of virulence genes, such as capsular biosyn-
thesis genes [16].
Phase variation of transcriptional regulators similarly can lead to global changes in gene
transcription (Fig 1, bottom). For example, Bordetella pertussis switches between virulent and
avirulent states through the modulation of the BvgAS two-component system (TCS) [17]. The
bvgS gene contains a cytosine tract in its coding region and SSR-mediated variation in the
number of cytosines affects BvgS production and transcription of BvgAS-regulated virulence
genes [17, 18]. In C. difficile, two invertible elements lie upstream of the colony morphology
regulator genes cmrRST and the flagellar flgB operon, which each encode transcriptional regu-
lators [8, 19]. The cmrRST operon encodes a noncanonical TCS composed of a predicted histi-
dine kinase, CmrS, and two putative response regulators with DNA binding domains, CmrR
and CmrT [19]. CmrRST modulates multiple C. difficile phenotypes: colony morphology, bio-
film formation, swimming motility, cell shape, and virulence in a model of acute disease [19].
Phase variation of CmrRST therefore has the capacity to coordinately regulate genes involved
in these phenotypes. The 23 kb flgB operon contains the alternative sigma factor gene sigD,
which is therefore also subject to phase variation [8]. In addition to coordinating the transcrip-
tion of flagellar genes, SigD promotes the transcription of the genes encoding the toxins, TcdA
and TcdB, and a number of other genes [20, 21]. Thus, phase variation of SigD concomitantly
controls production of flagella, toxins, and more.
Five additional invertible elements that flip by site-specific recombination have been identi-
fied in C. difficile R20291 [7, 8, 19, 22]. Two are present upstream of genes encoding phospho-
diesterases (PDEs) that degrade the cyclic diguanylate (c-di-GMP) signaling molecule, which
is known to control the transition between free-living and adherent, sessile states in numerous
bacterial species, including C. difficile [23, 24]. Hypothetically, phase variation of these PDEs
could cause heterogeneity in intracellular c-di-GMP levels among individual bacteria and,
consequently, in c-di-GMP regulated phenotypes such as swimming motility [25].
Interestingly, several of the targets of phase variation in C. difficile share a common feature:
Inversion of the upstream DNA element is mediated by a single tyrosine site-specific recombi-
nase, RecV [22]. Inversion of multiple, distinct sequences by RecV provides C. difficile with a
mechanism to introduce extensive heterogeneity into the population (simplified in Fig 1, mid-
dle). Such a large pool of variants may improve the survival of C. difficile in the intestinal tract.
Similarly, in the intestinal opportunistic pathogen Bacteroides fragilis, the site-specific recom-
binase Mpi mediates inversion of seven invertible elements containing promoters that regulate
genes involved in the production of different capsular exopolysaccharides [26].
How does the host environment influence phenotypic
heterogeneity?
Many important human pathogens phase vary factors that influence their virulence [27], and
new studies highlight the impact of the phenomenon on important nosocomial pathogens.
Recent work by Tipton and colleagues describes the phase variation of Acinetobacter
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baumannii between two distinct colony morphologies. These variants, termed opaque and
translucent, differ in a number of in vitro phenotypes, including motility, biofilm formation,
cell shape, antibiotic resistance, capsule production, and resistance to immune components
[28, 29]. Additionally, the opaque variant is more virulent than the translucent in two infection
models, wax moth larvae (Galleria mellonella) and murine pneumonia [28, 29]. A. baumannii
isolates obtained from blood cultures of five patients yielded only opaque colonies, suggesting
that the opaque variant is selected during human bloodstream infection [29]. The underlying
phase variation mechanism remains to be characterized but correlates with expression of an
OmpR/EnvZ TCS orthologue and the expression of a TetR family transcriptional regulator
[29, 30]. Because A. baumannii exists in both the environment and host, the opaque phenotype
may be beneficial in the context of infection, but not in the external environment. Alterna-
tively, the translucent variant may be beneficial in other host contexts. A. baumannii can colo-
nize a number of body sites, and the phenotypically distinct variants may be better suited to a
particular niche. This concept of higher fitness of certain phase variants in particular infection
sites has been demonstrated for Haemophilus influenzae, where certain phase variable genes
are OFF in one infection site (e.g., middle ear infection) but ON in another context, e.g., inva-
sive disease [3].
As noted above, phase variation of the CmrRST in C. difficile impacts multiple phenotypes,
including virulence [19]. Phase switching between variants was shown to occur in vivo; a
CmrRST phase-ON inoculum converted to a predominantly phase-OFF population by the
endpoint of infection [19]. These results imply that the phase-ON state is detrimental to C. dif-
ficile in this infection model. However, the high conservation of the cmrRST locus across C. dif-
ficile strains suggests that this regulatory system confers some benefit. An analysis of the spatial
and temporal distribution of cmrRST-expressing cells during infection could shed light on the
shifts in CmrRST heterogeneity during infection and on the host selective pressures impacting
the population.
Determining the molecular basis and fitness benefits of phase variation and phenotypic het-
erogeneity in bacterial pathogens will provide insight into pathogenic mechanisms and may
influence the development of preventive and therapeutic options. For example, if a vaccine or
therapeutic target is phase variable, then the pathogen may escape the immune response or
treatment. However, if we understand the selective pressures leading to population shifts or
block the variation mechanism, we may be able to ensure the entire population remains vul-
nerable, improving drug efficacy and patient outcomes.
References
1. Jiang X., et al., Invertible promoters mediate bacterial phase variation, antibiotic resistance, and host
adaptation in the gut. Science, 2019. 363(6423): p. 181–187. https://doi.org/10.1126/science.aau5238
PMID: 30630933
2. Armbruster C.R., et al., Heterogeneity in surface sensing suggests a division of labor in Pseudomonas
aeruginosa populations. Elife, 2019. 8.
3. Phillips Z.N., et al., Phase-variable bacterial loci: how bacteria gamble to maximise fitness in changing
environments. Biochem Soc Trans, 2019. 47(4): p. 1131–1141. https://doi.org/10.1042/BST20180633
PMID: 31341035
4. van der Woude M.W. and Baumler A.J., Phase and antigenic variation in bacteria. Clin Microbiol Rev,
2004. 17(3): p. 581–611. https://doi.org/10.1128/CMR.17.3.581-611.2004 PMID: 15258095
5. Freitag C.S., et al., Genetic analysis of the phase variation control of expression of type 1 fimbriae in
Escherichia coli. J Bacteriol, 1985. 162(2): p. 668–75. PMID: 2859269
6. Eisenstein B.I., Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control. Sci-
ence, 1981. 214(4518): p. 337–9. https://doi.org/10.1126/science.6116279 PMID: 6116279
PLOS PATHOGENS
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008439 May 21, 2020 5 / 7
7. Emerson J.E., et al., A novel genetic switch controls phase variable expression of CwpV, a Clostridium
difficile cell wall protein. Mol Microbiol, 2009. 74(3): p. 541–56. https://doi.org/10.1111/j.1365-2958.
2009.06812.x PMID: 19656296
8. Anjuwon-Foster B.R. and Tamayo R., A genetic switch controls the production of flagella and toxins in
Clostridium difficile. PLoS Genet, 2017. 13(3): p. e1006701. https://doi.org/10.1371/journal.pgen.
1006701 PMID: 28346491
9. Schwan W.R., Regulation of fim genes in uropathogenic Escherichia coli. World J Clin Infect Dis, 2011.
1(1): p. 17–25. https://doi.org/10.5495/wjcid.v1.i1.17 PMID: 23638406
10. Abraham J.M., et al., An invertible element of DNA controls phase variation of type 1 fimbriae of Escher-
ichia coli. Proc Natl Acad Sci U S A, 1985. 82(17): p. 5724–7. https://doi.org/10.1073/pnas.82.17.5724
PMID: 2863818
11. Schilling J.D., Mulvey M.A., and Hultgren S.J., Structure and function of Escherichia coli type 1 pili: new
insight into the pathogenesis of urinary tract infections. J Infect Dis, 2001. 183 Suppl 1: p. S36–40.
12. Gunther N.W. t., et al., Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial
mutants in which the invertible element is phase-locked on or off. Infect Immun, 2002. 70(7): p. 3344–
54. https://doi.org/10.1128/IAI.70.7.3344-3354.2002 PMID: 12065472
13. Snyder J.A., et al., Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis
isolate during urinary tract infection. Infect Immun, 2006. 74(2): p. 1387–93. https://doi.org/10.1128/IAI.
74.2.1387-1393.2006 PMID: 16428790
14. Srikhanta Y.N., et al., The phasevarion: a genetic system controlling coordinated, random switching of
expression of multiple genes. Proc Natl Acad Sci U S A, 2005. 102(15): p. 5547–51. https://doi.org/10.
1073/pnas.0501169102 PMID: 15802471
15. Atack J.M., et al., Phasevarions of Bacterial Pathogens: Methylomics Sheds New Light on Old Ene-
mies. Trends Microbiol, 2018. 26(8): p. 715–726. https://doi.org/10.1016/j.tim.2018.01.008 PMID:
29452952
16. Manso A.S., et al., A random six-phase switch regulates pneumococcal virulence via global epigenetic
changes. Nat Commun, 2014. 5: p. 5055. https://doi.org/10.1038/ncomms6055 PMID: 25268848
17. Decker K.B., et al., The Bordetella pertussis model of exquisite gene control by the global transcription
factor BvgA. Microbiology, 2012. 158(Pt 7): p. 1665–76. https://doi.org/10.1099/mic.0.058941-0 PMID:
22628479
18. Stibitz S., et al., Phase variation in Bordetella pertussis by frameshift mutation in a gene for a novel two-
component system. Nature, 1989. 338(6212): p. 266–9. https://doi.org/10.1038/338266a0 PMID:
2537932
19. Garrett E.M., et al., Phase variation of a signal transduction system controls Clostridioides difficile col-
ony morphology, motility, and virulence. PLoS Biol, 2019. 17(10): p. e3000379. https://doi.org/10.1371/
journal.pbio.3000379 PMID: 31658249
20. El Meouche I., et al., Characterization of the SigD regulon of C. difficile and its positive control of toxin
production through the regulation of tcdR. PLoS ONE, 2013. 8(12): p. e83748. https://doi.org/10.1371/
journal.pone.0083748 PMID: 24358307
21. McKee R.W., et al., The second messenger cyclic di-GMP regulates Clostridium difficile toxin produc-
tion by controlling expression of sigD. J Bacteriol, 2013. 195(22): p. 5174–85. https://doi.org/10.1128/
JB.00501-13 PMID: 24039264
22. Sekulovic O., et al., Genome-wide detection of conservative site-specific recombination in bacteria.
PLoS Genet, 2018. 14(4): p. e1007332. https://doi.org/10.1371/journal.pgen.1007332 PMID:
29621238
23. Romling U., Galperin M.Y., and Gomelsky M., Cyclic di-GMP: the first 25 years of a universal bacterial
second messenger. Microbiol Mol Biol Rev, 2013. 77(1): p. 1–52. https://doi.org/10.1128/MMBR.
00043-12 PMID: 23471616
24. Purcell E.B. and Tamayo R., Cyclic diguanylate signaling in Gram-positive bacteria. FEMS Microbiol
Rev, 2016. 40(5): p. 753–73. https://doi.org/10.1093/femsre/fuw013 PMID: 27354347
25. Hengge R., Principles of c-di-GMP signalling in bacteria. Nat Rev Microbiol, 2009. 7(4): p. 263–73.
https://doi.org/10.1038/nrmicro2109 PMID: 19287449
26. Coyne M.J., et al., Mpi recombinase globally modulates the surface architecture of a human commensal
bacterium. Proc Natl Acad Sci U S A, 2003. 100(18): p. 10446–51. https://doi.org/10.1073/pnas.
1832655100 PMID: 12915735
27. Weigel W.A. and Dersch P., Phenotypic heterogeneity: a bacterial virulence strategy. Microbes Infect,
2018. 20(9–10): p. 570–577. https://doi.org/10.1016/j.micinf.2018.01.008 PMID: 29409898
PLOS PATHOGENS
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008439 May 21, 2020 6 / 7
28. Tipton K.A., Dimitrova D., and Rather P.N., Phase-Variable Control of Multiple Phenotypes in Acineto-
bacter baumannii Strain AB5075. J Bacteriol, 2015. 197(15): p. 2593–9. https://doi.org/10.1128/JB.
00188-15 PMID: 26013481
29. Chin C.Y., et al., A high-frequency phenotypic switch links bacterial virulence and environmental sur-
vival in Acinetobacter baumannii. Nat Microbiol, 2018. 3(5): p. 563–569. https://doi.org/10.1038/
s41564-018-0151-5 PMID: 29693659
30. Tipton K.A. and Rather P.N., An ompR-envZ Two-Component System Ortholog Regulates Phase Vari-
ation, Osmotic Tolerance, Motility, and Virulence in Acinetobacter baumannii Strain AB5075. J Bacter-
iol, 2017. 199(3): e00705–16. https://doi.org/10.1128/JB.00705-16 PMID: 27872182
31. Anjuwon-Foster B.R. and Tamayo R., Phase variation of Clostridium difficile virulence factors. Gut
Microbes, 2018. 9(1): p. 76–83. https://doi.org/10.1080/19490976.2017.1362526 PMID: 28806147
PLOS PATHOGENS
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008439 May 21, 2020 7 / 7
